Corpus Intelligence IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP 2026-04-26 12:36 UTC
IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP
Investment Committee Memorandum | VA | 40 beds | Grade C | EBITDA uplift $1.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ENCOMPASS HEALTH REHABILITATION HOSP

CCN 493028 | HENRICO, VA | 40 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ENCOMPASS HEALTH REHABILITATION HOSP is a 40-bed suburban community hospital in HENRICO, VA with $23.2M in net patient revenue and a 15.0% operating margin. The hospital serves a payer mix of 59.3% Medicare, 0.1% Medicaid, and 40.7% commercial.

Thesis: Turnaround. Our ML models identify $1.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 15.0% to 22.4% (+736bps).

Net Revenue HCRIS$23.2M
Current EBITDA COMPUTED$3.5M
Operating Margin COMPUTED15.0%
Occupancy HCRIS88.2%
Revenue / Bed COMPUTED$581K
Net-to-Gross HCRIS80.6%
Distress Probability ML46.0%

2. Market Context & Competitive Position

111
VA Hospitals
4.4%
State Median Margin
41
Comparable Hospitals

VA has 111 Medicare-certified hospitals with a median operating margin of 4.4%. The target's margin of 15.0% places it above the state median. Among 41 size-comparable peers (20-80 beds), the median margin is 4.0%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (20-80), prioritizing same-state peers. 41 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ENCOMPASS HEALTH REHABILITATIO (Target)VA40$23.2M15.0%
LONESOME PINE HOSPITALVA56$175.6M17.2%
CULPEPER MEMORIAL HOSPITALVA70$153.9M9.3%
COMMUNITY MEMORIAL HOSPITALVA66$135.2M-31.0%
STAFFORD HOSPITALVA61$127.9M5.7%
SOUTHSIDE COMMUNITY HOSPITALVA80$113.4M7.3%
RIVERSIDE WALTER REEDVA67$108.2M12.5%
HALIFAX REGIONAL HOSPITALVA44$104.6M-16.5%
SHORE MEMORIAL HOSPITALVA52$103.1M11.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$488K+210bp18mo
Cost to Collect4.5%2.5%$465K+200bp12mo
Denial Rate Reduction12.0%6.5%$460K+198bp12mo
A/R Days Reduction5200.0%3800.0%$283K+122bp9mo
Clean Claim Rate88.0%96.0%$15K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$488K
Cost to Collect
$465K
Denial Rate Reduction
$460K
A/R Days Reduction
$283K
Clean Claim Rate
$15K
Total EBITDA Uplift$1.7M
Current EBITDA$3.5M
+ RCM Uplift+$1.7M
Pro Forma EBITDA$5.2M
Current Margin15.0%
Pro Forma Margin22.4%
WC Released (1x)$891K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$5.4M$40.1M7.47x49.5%
Base (11x exit)10.0x11.0x$5.4M$45.9M8.54x53.6%
Bull Case9.0x11.0x$4.8M$53.3M11.02x61.6%
Bull (12x exit)9.0x12.0x$4.8M$59.6M12.32x65.2%
Bear Case11.0x10.0x$5.9M$29.8M5.05x38.2%
Bear (11x exit)11.0x11.0x$5.9M$34.7M5.88x42.5%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 59.3% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 41 hospitals with 20-80 beds
  • Same-state prioritization (n=42)
  • Comp margins: P25=-12.9% / P50=4.0% / P75=13.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.